Cite
HARVARD Citation
Zer, A. et al. (2016). Pooled Analysis of the Prognostic and Predictive Value ofKRASMutation Status and Mutation Subtype in Patients with Non–Small Cell Lung Cancer Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. Journal of thoracic oncology. 11 (3), p. . [Online].